Literature DB >> 19396025

The genetics of idiopathic hypogonadotropic hypogonadism:unraveling the biology of human sexual development.

Amrit Bhangoo1, Elka Jacobson-Dickman.   

Abstract

Idiopathic Hypogonadotropic Hypogonadism (IHH), a syndrome of GnRH deficiency, is characterized by varying degrees of sexual development disruption. When associated with anosmia, it is termed Kallmann Syndrome (KS). Although it was identified as a hereditary disorder over half a century ago, only during the last two decades have specific putative IHH genes been revealed, including: KAL1, GnRHR, FGFR1, GPR54, PROK2, PROKR2, FGF8, CHD7, TAC3 and TAC3R. Human mutations have shed light on the molecular control of GnRH neuronal embryogenesis and have elucidated elements critical in sexual development. Furthermore, the newly proposed oligogenic model has challenged the dogma of IHH being a single gene disorder and has heightened appreciation for the functional overlap of distinct signaling systems. This review offers an historical perspective to gene discoveries in IHH, genotype-phenotype correlations, and finally, discussion of the evolving complexity of the new IHH genetic model, no longer simply characterized by Mendelian inheritance.

Entities:  

Mesh:

Year:  2009        PMID: 19396025

Source DB:  PubMed          Journal:  Pediatr Endocrinol Rev        ISSN: 1565-4753


  9 in total

1.  Etiological evaluation of adolescents with primary amenorrhea.

Authors:  Erdal Eren; Halil Saglam; Esra Deniz Papatya Cakir; Omer Tarim
Journal:  Indian J Pediatr       Date:  2013-11-01       Impact factor: 1.967

Review 2.  Genetic determinants of pubertal timing in the general population.

Authors:  Zofia K Z Gajdos; Katherine D Henderson; Joel N Hirschhorn; Mark R Palmert
Journal:  Mol Cell Endocrinol       Date:  2010-02-06       Impact factor: 4.102

3.  Nonsense mutations in FGF8 gene causing different degrees of human gonadotropin-releasing deficiency.

Authors:  Ericka B Trarbach; Ana Paula Abreu; Leticia Ferreira Gontijo Silveira; Heraldo Mendes Garmes; Maria Tereza M Baptista; Milena Gurgel Teles; Elaine M F Costa; Moosa Mohammadi; Nelly Pitteloud; Berenice B Mendonca; Ana Claudia Latronico
Journal:  J Clin Endocrinol Metab       Date:  2010-05-12       Impact factor: 5.958

4.  Deletion of Otx2 in GnRH neurons results in a mouse model of hypogonadotropic hypogonadism.

Authors:  Daniel Diaczok; Sara DiVall; Isao Matsuo; Fredric E Wondisford; Andrew M Wolfe; Sally Radovick
Journal:  Mol Endocrinol       Date:  2011-03-24

5.  Nasal embryonic LHRH factor (NELF) mutations in patients with normosmic hypogonadotropic hypogonadism and Kallmann syndrome.

Authors:  Ning Xu; Hyung-Goo Kim; Balasubramanian Bhagavath; Sung-Gyu Cho; Jae Ho Lee; Kyungsoo Ha; Irene Meliciani; Wolfgang Wenzel; Robert H Podolsky; Lynn P Chorich; Kathryn A Stackhouse; Anna M H Grove; Lawrence N Odom; Metin Ozata; David P Bick; Richard J Sherins; Soo-Hyun Kim; Richard S Cameron; Lawrence C Layman
Journal:  Fertil Steril       Date:  2011-02-15       Impact factor: 7.329

6.  A phenotypic high throughput screening assay for the identification of pharmacoperones for the gonadotropin releasing hormone receptor.

Authors:  P Michael Conn; Emery Smith; Timothy Spicer; Peter Chase; Louis Scampavia; Jo Ann Janovick
Journal:  Assay Drug Dev Technol       Date:  2014-05       Impact factor: 1.738

Review 7.  Diagnosis of diseases of steroid hormone production, metabolism and action.

Authors:  John W Honour
Journal:  J Clin Res Pediatr Endocrinol       Date:  2009-08-02

8.  Posttranslational Modification Defects in Fibroblast Growth Factor Receptor 1 as a Reason for Normosmic Isolated Hypogonadotropic Hypogonadism.

Authors:  Hui Ying; Yan Sun; Huixiao Wu; Wenyu Jia; Qingbo Guan; Zhao He; Ling Gao; Jiajun Zhao; Yiming Ji; Guimei Li; Chao Xu
Journal:  Oxid Med Cell Longev       Date:  2020-11-21       Impact factor: 6.543

9.  TAC3/TACR3 System Function in the Catadromous Migration Teleost, Anguilla japonica.

Authors:  Chenpeng Zuo; Likang Lyu; Wenhui Zou; Haishen Wen; Yun Li; Xin Qi
Journal:  Front Endocrinol (Lausanne)       Date:  2022-07-22       Impact factor: 6.055

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.